Hearing preservation procedures in acoustic neuroma surgery entail a risk of recurrent tumor either from the preserved cochlear nerve (tumor cell remains or late degeneration) or from tumor remnants left in the lateral end of the internal auditory canal. There is disagreement about the frequency of such tumor remnants, and the diagnostic modalities are not precise. Magnetic resonance imaging with gadolinium-DTPA enhancement is effective in diagnosing a primary case, but may not be so clear for small residual or recurrent tumors. A review of the literature concerning residual/recurrent tumor after "total" removal in functional unilateral acoustic neuroma surgery provided several reports,1-9 but systematic studies were lacking.This study of a series of 104 acoustic neuroma cases operated on with a hearing preservation procedure assessed the rates of residual or recurrent tumor and the imaging data that were significant for its diagnosis.
MATERIALS AND METHODSDuring the period 1975 to 1993, 104 consecutive patients presenting with acoustic neuroma were operated on with the same hearing preservation procedure: the suboccipital approach with meatotomy and direct exposure of the lateral end of the internal auditory canal (IAC). The procedure involved a bone resection of the posterior and part of the superior and inferior walls of the IAC and used as landmarks the vestibular aqueduct, the common crus, and the nonampullated crura of the posterior and the superior semicircular canals. In every case, the surgeon 105
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.